CIK 0001664710
- Non-accelerated filer
- Smaller reporting company
Keros Therapeutics, Inc.
Sign in to watch- Ticker
- KROS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 811173868
- Phone
- +1 617-314-6297
- Business address
- 1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA, 02421
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,619
- in 1 filing, $6K under 10b5-1 plans
Net −$5,619. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-03 | Knowles Julius Director | Sale | −2,406 | $56.82 | $137K | 249,130 |
| 2022-01-03 | Knowles Julius Director | Sale | −5,094 | $57.83 | $295K | 361,644 |
| 2022-01-03 | Knowles Julius Director | Sale | −3,318 | $57.83 | $192K | 245,812 |
| 2022-01-03 | Knowles Julius Director | Sale | −5,236 | $58.96 | $309K | 356,408 |
| 2022-01-03 | Knowles Julius Director | Sale | −3,412 | $58.96 | $201K | 242,400 |
| 2022-01-03 | Knowles Julius Director | Sale | −249 | $59.40 | $15K | 356,159 |
| 2022-01-03 | Knowles Julius Director | Sale | −162 | $59.40 | $10K | 242,238 |
| 2021-12-15 | Lachey Jennifer Chief Scientific Officer | Exercise or conversion | +735 | $0.30 | $221 | 86,435 |
| 2021-12-15 | Lachey Jennifer Chief Scientific Officer | Sale | −735 | $50.00 | $37K | 85,700 |
| 2021-12-15 | Lachey Jennifer Chief Scientific Officer | Exercise or conversion · Employee Stock Option (right to buy) | −735 | 95,255 | ||
| 2021-12-13 | Lachey Jennifer Chief Scientific Officer | Exercise or conversion | +1,915 | $0.30 | $575 | 87,615 |
| 2021-12-13 | Lachey Jennifer Chief Scientific Officer | Sale | −1,518 | $50.11 | $76K | 86,097 |
| 2021-12-13 | Lachey Jennifer Chief Scientific Officer | Sale | −390 | $52.22 | $20K | 85,707 |
| 2021-12-13 | Lachey Jennifer Chief Scientific Officer | Sale | −7 | $53.64 | $375 | 85,700 |
| 2021-12-13 | Lachey Jennifer Chief Scientific Officer | Exercise or conversion · Employee Stock Option (right to buy) | −1,915 | 95,990 | ||
| 2021-12-02 | Knowles Julius Director | Sale | −79 | $51.99 | $4K | 385,673 |
| 2021-12-02 | Knowles Julius Director | Sale | −52 | $52.00 | $3K | 261,486 |
| 2021-12-02 | Knowles Julius Director | Sale | −6,372 | $53.17 | $339K | 379,301 |
| 2021-12-02 | Knowles Julius Director | Sale | −4,155 | $53.17 | $221K | 257,331 |
| 2021-12-02 | Knowles Julius Director | Sale | −8,747 | $53.86 | $471K | 370,554 |
Page 13 of 36 · 707 trades